Showing results (1501-1510 of 1,985) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|January 15, 2008
Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanismChristopher C Rowe, Uwe Ackerman, William Browne, et al.The Lancet. Neurology|March 21, 2014
Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screeningRobert D Brown, Joseph P BroderickThe Lancet. Neurology|July 15, 2026
The role of the gut microbiome in mediating neuroinflammation in immune-based neurological disordersClaude Steriade, Nicola Segata, Deepak SaxenaThe Lancet. Neurology|July 15, 2026
Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trialHubert H Fernandez, Perminder Bhatia, Leslie Cloud, et al.The Lancet. Neurology|August 12, 2026
Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalitiesSabrina Kalam, Judith Stellman, Robert Bell, et al.The Lancet. Neurology|August 12, 2026
Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort studyPiero Perucca, Charles B Malpas, Alexander Berry-Noronha, et al.The Lancet. Neurology|October 25, 2020
Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapiesGalen E B Wright, Hailey Findlay Black, Jennifer A Collins, et al.The Lancet. Neurology|December 22, 2022
Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trialMelinda B Roaldsen, Agnethe Eltoft, Tom Wilsgaard, et al.The Lancet. Neurology|June 19, 2021
Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trialLeopoldine A Wilbrink, Ilse F de Coo, Patty G G Doesborg, et al.The Lancet. Neurology|June 19, 2021
Progress towards therapies for disease modification in Parkinson's diseaseNirosen Vijiaratnam, Tanya Simuni, Oliver Bandmann, et al.Pageof 199